4th Quarter - Report

HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.

LobbyistCovered position, as disclosed
MAGGIE DAVIS Legal Fellow, Rep. Jan Schakowsky, 2012.
KATHRYN DIBITETTO Senior Legislative Assistant, Rep. Mike McMahon, 2009-2011
WYETH RUTHVEN Press Secretary, Rep. Lloyd Doggett, 2006-2009; Staff Assistant, Sen. Fritz Hollings, 1996-1999

Contacted: SENATE; Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Federal Emergency Management Agency (FEMA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); White House Office; Commerce, Dept of (DOC); Federal Maritime Commission

Bills named: S. 891 (119th), H.R. 2213 (119th), S. 998 (119th)

Transportation TRA

S.257, the Promoting Resilient Supply Chains Act of 2025.

LobbyistCovered position, as disclosed
MAGGIE DAVIS New Legal Fellow, Rep. Jan Schakowsky, 2012.
KATHRYN DIBITETTO Senior Legislative Assistant, Rep. Mike McMahon, 2009-2011
WYETH RUTHVEN Press Secretary, Rep. Lloyd Doggett, 2006-2009; Staff Assistant, Sen. Fritz Hollings, 1996-1999

Contacted: Federal Maritime Commission; Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Transportation, Dept of (DOT)

Bills named: S. 257 (119th)

Tariff (miscellaneous tariff bills) TAR

Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

LobbyistCovered position, as disclosed
MAGGIE DAVIS New Legal Fellow, Rep. Jan Schakowsky, 2012.
KATHRYN DIBITETTO Senior Legislative Assistant, Rep. Mike McMahon, 2009-2011
WYETH RUTHVEN Press Secretary, Rep. Lloyd Doggett, 2006-2009; Staff Assistant, Sen. Fritz Hollings, 1996-1999

Contacted: SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2213 (119th), S. 998 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.